Clinical Impact of High-Dose Corticosteroids on Healthcare Resource Utilization and Steroid-Related Complications in Patients with Myasthenia Gravis in Japan
Use of high-dose OCS in patients with MG was associated with adverse outcomes, including increased rates of long-term hospitalizations and clinical complications.
Authors
- Miina Waratani (ORCID: https://orcid.org/0000-0002-4648-7454)
- Naoki Numajiri (ORCID: https://orcid.org/0009-0007-9873-721X)
- Masanori Takahashi (ORCID: https://orcid.org/0000-0002-5513-5012)
- Takanori Yamamoto (ORCID: https://orcid.org/0000-0002-5835-7120)
Institutions
- AstraZeneca (United Kingdom) (GB)
- Osaka University of Economics (JP)
- Osaka City University (JP)
- AstraZeneca (Singapore) (SG)
- AstraZeneca (Japan) (JP)
- Alexion Pharma (Switzerland) (CH)
- The University of Osaka (JP)
Publication Details
- Journal
- Neurology and Therapy
- Published
- 2025-11-12
- DOI
- https://doi.org/10.1007/s40120-025-00850-7
- Primary Topic
- Myasthenia Gravis and Thymoma
- Type
- article
- Field-Weighted Citation Impact
- 0.00